Intercontinental Exchange, Inc. (ICE) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 2.00%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | 2.00% | Share-based compensation / revenue. Period ending 2026-06-30. $268.00M ÷ $13.43B × 100 ≈ 2.00% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | 13.43B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 268.00M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 5.47B USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $13.43B | $268.00M | $5.47B | (m) | (m) | 2.00% | (m) | (m) |
| 2026-03-31 | (m) | $13.08B | $259.00M | $5.37B | (m) | (m) | 1.98% | (m) | (m) |
| 2025-12-31 | (m) | $12.64B | $238.00M | $4.93B | (m) | (m) | 1.88% | (m) | (m) |
| 2025-09-30 | (m) | $12.53B | $230.00M | $4.77B | (m) | (m) | 1.84% | (m) | (m) |
| 2025-06-30 | (m) | $12.55B | $230.00M | $4.70B | (m) | (m) | 1.83% | (m) | (m) |
| 2025-03-31 | (m) | $12.19B | $230.00M | $4.47B | (m) | (m) | 1.89% | (m) | (m) |
| 2024-12-31 | (m) | $11.76B | $231.00M | $4.31B | (m) | (m) | 1.96% | (m) | (m) |
| 2024-09-30 | (m) | $11.40B | $264.00M | $4.16B | (m) | (m) | 2.32% | (m) | (m) |
| 2024-06-30 | (m) | $10.79B | $286.00M | $3.90B | (m) | (m) | 2.65% | (m) | (m) |
| 2024-03-31 | (m) | $10.23B | $274.00M | $3.79B | $873.00M | (m) | 2.68% | 4.34× | Reported |
| 2023-12-31 | (m) | $9.90B | $257.00M | $3.69B | $808.00M | (m) | 2.60% | 4.57× | Reported |
| 2023-09-30 | (m) | $9.61B | $203.00M | $3.63B | $733.00M | (m) | 2.11% | 4.96× | Reported |
| 2023-06-30 | (m) | $9.57B | $164.00M | $3.70B | $703.00M | (m) | 1.71% | 5.26× | Reported |
| 2023-03-31 | (m) | $9.65B | $157.00M | $3.62B | $689.00M | (m) | 1.63% | 5.25× | Reported |
| 2022-12-31 | (m) | $9.64B | $155.00M | $3.64B | $616.00M | (m) | 1.61% | 5.91× | Reported |
| 2022-09-30 | (m) | $9.59B | $192.00M | $3.65B | $542.00M | (m) | 2.00% | 6.74× | Reported |
| 2022-06-30 | (m) | $9.48B | $191.00M | $3.62B | $474.00M | (m) | 2.02% | 7.64× | Reported |
| 2022-03-31 | (m) | $9.20B | $190.00M | $3.55B | $419.00M | (m) | 2.07% | 8.47× | Reported |
| 2021-12-31 | (m) | $9.17B | $188.00M | $3.45B | $423.00M | (m) | 2.05% | 8.15× | Reported |
| 2021-09-30 | (m) | $9.07B | $146.00M | $3.35B | $433.00M | (m) | 1.61% | 7.73× | Reported |
| 2021-06-30 | (m) | $8.73B | $139.00M | $3.10B | $414.00M | (m) | 1.59% | 7.48× | Reported |
| 2021-03-31 | (m) | $8.56B | $134.00M | $3.04B | $392.00M | (m) | 1.57% | 7.76× | Reported |
| 2020-12-31 | (m) | $8.24B | $139.00M | $3.03B | $357.00M | (m) | 1.69% | 8.50× | Reported |
| 2020-09-30 | (m) | $7.68B | $144.00M | $2.88B | $316.00M | (m) | 1.88% | 9.10× | Reported |
| 2020-06-30 | (m) | $7.41B | $148.00M | $2.95B | $299.00M | (m) | 2.00% | 9.88× | Reported |
| 2020-03-31 | (m) | $7.08B | $151.00M | $2.89B | $286.00M | (m) | 2.13% | 10.10× | Reported |
| 2019-12-31 | (m) | $6.55B | $139.00M | $2.67B | $285.00M | (m) | 2.12% | 9.38× | Reported |
| 2019-09-30 | (m) | $6.56B | $137.00M | $2.73B | $285.00M | (m) | 2.09% | 9.57× | Reported |
| 2019-06-30 | (m) | $6.36B | $133.00M | $2.62B | $279.00M | (m) | 2.09% | 9.40× | Reported |
| 2019-03-31 | (m) | $6.28B | $130.00M | $2.60B | $263.00M | (m) | 2.07% | 9.88× | Reported |
| 2018-12-31 | (m) | $6.28B | $130.00M | $2.58B | $244.00M | (m) | 2.07% | 10.59× | Reported |
| 2018-09-30 | (m) | $4.83B | $126.00M | $2.50B | $223.00M | (m) | 2.61% | 11.21× | Reported |
| 2018-06-30 | (m) | $4.80B | $128.00M | $2.49B | $204.00M | (m) | 2.67% | 12.22× | Reported |
| 2018-03-31 | (m) | $4.74B | $130.00M | $2.45B | $194.00M | (m) | 2.74% | 12.61× | Reported |
| 2017-12-31 | (m) | $4.63B | $135.00M | $2.38B | $187.00M | (m) | 2.92% | 12.72× | Reported |
| 2017-09-30 | (m) | $5.88B | $136.00M | $2.35B | $181.00M | (m) | 2.31% | 12.96× | Reported |
| 2017-06-30 | (m) | $5.86B | $132.00M | $2.22B | $178.00M | (m) | 2.25% | 12.49× | Reported |
| 2017-03-31 | (m) | $5.87B | $129.00M | $2.17B | $177.00M | (m) | 2.20% | 12.23× | Reported |
| 2016-12-31 | (m) | $5.96B | $124.00M | $2.17B | $178.00M | (m) | 2.08% | 12.17× | Reported |
| 2016-09-30 | (m) | $5.69B | $122.00M | $2.03B | $164.00M | (m) | 2.14% | 12.36× | Reported |
| 2016-06-30 | (m) | $5.46B | $124.00M | $1.99B | $141.00M | (m) | 2.27% | 14.13× | Reported |
| 2016-03-31 | (m) | $5.06B | $116.00M | $1.87B | $120.00M | (m) | 2.29% | 15.60× | Reported |
| 2015-12-31 | (m) | $4.68B | $111.00M | $1.75B | $97.00M | (m) | 2.37% | 18.04× | Reported |
| 2015-09-30 | (m) | $4.51B | $103.00M | $1.73B | $90.00M | (m) | 2.28% | 19.24× | Reported |
| 2015-06-30 | (m) | $4.37B | $95.00M | $1.62B | $91.00M | (m) | 2.17% | 17.82× | Reported |
| 2015-03-31 | (m) | $4.31B | $101.00M | $1.52B | $92.00M | (m) | 2.34% | 16.51× | Reported |
| 2014-12-31 | (m) | $4.22B | $97.00M | $1.45B | $96.00M | (m) | 2.30% | 15.08× | Reported |
| 2014-09-30 | (m) | $3.81B | $95.00M | $1.21B | $100.00M | (m) | 2.49% | 12.11× | Reported |
| 2014-06-30 | (m) | $3.14B | $83.00M | $1.08B | $87.00M | (m) | 2.64% | 12.45× | Reported |
| 2014-03-31 | (m) | $2.64B | $71.00M | $999.00M | $73.00M | (m) | 2.69% | 13.68× | Reported |
| 2013-12-31 | (m) | $1.79B | $64.00M | $790.00M | $56.00M | (m) | 3.57% | 14.11× | Reported |
| 2013-09-30 | (m) | (m) | (m) | $820.00M | (m) | (m) | (m) | (m) | (m) |
| 2013-06-30 | (m) | (m) | (m) | $812.00M | (m) | (m) | (m) | (m) | (m) |
| 2013-03-31 | (m) | (m) | (m) | $802.00M | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | (m) | $1.36B | $52.00M | $827.00M | $39.00M | (m) | 3.82% | 21.21× | Reported |
| 2012-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | (m) | $1.33B | $53.00M | $793.00M | $35.00M | (m) | 3.99% | 22.66× | Reported |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NASDAQ, INC. (NDAQ) | United States | $52.840B | 22.52 |
| Cboe Global Markets, Inc. (CBOE) | United States | $27.926B | 18.70 |
| LPL Financial Holdings Inc. (LPLA) | United States | $23.839B | 22.38 |
| CME GROUP INC. (CME) | United States | $17.920B | 4.10 |
| StoneX Group Inc. (SNEX) | United States | $8.386B | 26.96 |